Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cervical Cancer Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05981157
What this trial is testing

Anrotinib and Tirelizumab in First-line Treatment of RM-NPC

Who this might be right for
Nasopharyngeal Carcinoma
Zhongshan People's Hospital, Guangdong, China 27
Early research (Phase 1)Study completedNCT03547388
What this trial is testing

Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on the Tumor Microenvironment

Who this might be right for
Head and Neck NeoplasmsRecurrence Tumor
Charite University, Berlin, Germany 10
Not applicableUnknownNCT05900583
What this trial is testing

Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.

Who this might be right for
Minimal Residual DiseaseEsophageal Squamous Cell Carcinoma
Guangdong Provincial People's Hospital 50
Very early researchUnknownNCT04674488
What this trial is testing

TILs for Treatment of Metastatic or Recurrent Cervical Cancer

Who this might be right for
TILs, Metastatic or Recurrent Cervical Cancer
Shanghai OriginCell Therapeutics Co., Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT00020761
What this trial is testing

Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Jonsson Comprehensive Cancer Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT07668154
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC Participants

Who this might be right for
HNSCC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Ended earlyNCT01606566
What this trial is testing

Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.

Who this might be right for
Recurrent Head and Neck CancerCarcinoma, Squamous Cell of Head and Neck
PCI Biotech AS 26
Testing effectiveness (Phase 2)Looking for participantsNCT05726370
What this trial is testing

Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck CancerResectable Head and Neck Squamous Cell Carcinoma+2 more
Dana-Farber Cancer Institute 28
Testing effectiveness (Phase 2)UnknownNCT05659186
What this trial is testing

PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer

Who this might be right for
Thyroid Cancer
West China Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04955886
What this trial is testing

Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 14
Not applicableUnknownNCT04336696
What this trial is testing

Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0?

Who this might be right for
Papillary Thyroid Carcinoma
Bassem Mohamed Sieda 199
Large-scale testing (Phase 3)Study completedNCT03556839
What this trial is testing

Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix

Who this might be right for
Carcinoma of the Cervix, Stage IVB
Grupo Español de Investigación en Cáncer de Ovario 410
Not applicableStudy completedNCT00899821
What this trial is testing

Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07206563
What this trial is testing

Penfluridol for Relapsed/Refractory Small Cell Cancers

Who this might be right for
Small Cell CarcinomaSmall Cell Carcinoma of LungSmall Cell Lung Cancer ( SCLC )+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 33
Large-scale testing (Phase 3)WithdrawnNCT00041171
What this trial is testing

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Adult Solid TumorBreast CancerHead and Neck Cancer+3 more
Alliance for Clinical Trials in Oncology
Not applicableStudy completedNCT01466244
What this trial is testing

Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 42
Testing effectiveness (Phase 2)Ended earlyNCT00256295
What this trial is testing

Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Cancer of the Head and Neck
Sai-Hong Ignatius Ou 8
Testing effectiveness (Phase 2)Ended earlyNCT02633800
What this trial is testing

Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )

Who this might be right for
Head and Neck Neoplasms
Daiichi Sankyo 87
Large-scale testing (Phase 3)Study completedNCT03924986
What this trial is testing

Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer (NPC)

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Cancer
BeiGene 263
Testing effectiveness (Phase 2)Study completedNCT03194373
What this trial is testing

Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Michigan Rogel Cancer Center 21
Next Page